Get all your news in one place.
100's of premium titles.
One app.
Start reading
Wales Online
Wales Online
National
Max Channon

Japanese pharma company claims Ivermectin has 'antiviral effect' against Covid

A Japanese pharmaceutical company has said the controversial drug Ivermectin shows an 'antiviral effect' against Omicron and other Covid-19 coronavirus variants in joint non-clinical research.

Kowa Co Ltd, which has been working with the Kitasato University in Tokyo on testing the drug, has not provided further details.

The news was reported by Reuters, which misstated that ivermectin was 'effective' against Omicron in Phase III clinical trials, which are conducted in humans.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.